ページの作成:「<br><br><br>The most common treatment-emergent adverse events (AEs) related to PT-141 administration were nausea (40.4%), flushing (20.6%), and headache (12.0%). The only…」
(ページの作成:「<br><br><br>The most common treatment-emergent adverse events (AEs) related to PT-141 administration were nausea (40.4%), flushing (20.6%), and headache (12.0%). The only…」)